These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6091394)

  • 21. Physical Disabilities Related to the Depressive Mental States of Japanese Patients with Subacute Myelo-optico-neuropathy.
    Konishi T
    Intern Med; 2018 Sep; 57(18):2641-2645. PubMed ID: 29780125
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diminished skin vasodilator response to local heating in patients with long-standingsubacute myelo-optico-neuropathy.
    Yamanaka Y; Asahina M; Akaogi Y; Koyama Y; Hattori T
    J Neurol Sci; 2007 Sep; 260(1-2):214-8. PubMed ID: 17572442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myelo-optic neuropathy induced by clioquinol in animals.
    Tateishi J; Kuroda S; Saito A; Otsuki S
    Lancet; 1971 Dec; 2(7736):1263-4. PubMed ID: 4143622
    [No Abstract]   [Full Text] [Related]  

  • 24. Tongue strength in patients with subacute myelo-optico-neuropathy.
    Yamashita S; Nakama T; Ueda M; Honda S; Kimura E; Konagaya M; Ando Y
    J Clin Neurosci; 2018 Jan; 47():84-88. PubMed ID: 29054330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Fifity years after the identification of the cause of SMON].
    Kuru S
    Rinsho Shinkeigaku; 2021 Feb; 61(2):109-114. PubMed ID: 33504748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chinese acupuncture treatment for SMON patients.
    Katahira K; Kobayshi T; Higashida T; Kamae S; Nakajima Y; Fujimoto S
    Chin Med J (Engl); 1986 Nov; 99(11):910-1. PubMed ID: 2953563
    [No Abstract]   [Full Text] [Related]  

  • 27. Clioquinol intoxication occurring in the treatment of acrodermatitis enteropathica with reference to SMON outside of Japan.
    Hanakago R; Uono M
    Clin Toxicol; 1981 Dec; 18(12):1427-34. PubMed ID: 6460590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transient global amnesia due to clioquinol.
    Kaeser HE
    Acta Neurol Scand Suppl; 1984; 100():175-83. PubMed ID: 6237545
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Toward the complete understanding of the pathogenic mechanism of clioquinol-induced subacute myelo-optic neuropathy (SMON)].
    Katsuyama M
    Nihon Yakurigaku Zasshi; 2024; 159(2):78-82. PubMed ID: 38432923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subacute myelo-optic neuropathy and clioquinol. An epidemiological case-history for diagnosis.
    Meade TW
    Br J Prev Soc Med; 1975 Sep; 29(3):157-69. PubMed ID: 127638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. More on S.M.O.N.
    Lancet; 1971 Dec; 2(7736):1244. PubMed ID: 4143604
    [No Abstract]   [Full Text] [Related]  

  • 32. The Aggravation of Depression with Aging in Japanese Patients with Subacute Myelo-optico-neuropathy (SMON).
    Konishi T; Hayashi K; Sugiyama H
    Intern Med; 2017 Aug; 56(16):2119-2123. PubMed ID: 28781313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The neuropathology of subacute myelo-optico-neuropathy, "SMON", in the humans: --with special reference to the quinoform intoxication.
    Shiraki H
    Jpn J Med Sci Biol; 1975; 28 Suppl():101-64. PubMed ID: 136535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Analysis of SMON at 30 years after its outbreak ending: special reference to those patients with blindness].
    Konagaya M; Matsuoka Y; Nakae K; Iwashita H
    No To Shinkei; 2002 Jun; 54(6):473-80. PubMed ID: 12166096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Subsets of peripheral blood lymphocytes and ageing in patients with SMON].
    Matsuda M; Yanagisawa N; Tsukada N
    Arerugi; 1991 Sep; 40(9):1226-31. PubMed ID: 1835574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ethnic differences in drugs and xenobiotics. Clioquinol.
    Rose FC
    Prog Clin Biol Res; 1986; 214():323-30. PubMed ID: 2941765
    [No Abstract]   [Full Text] [Related]  

  • 37. Zinc deficiency, acrodermatitis enteropathica, optic atrophy, subacute myelo-optic neuropathy, and 5,7-dihalo-8-quinolinols.
    Sturtevant FM
    Pediatrics; 1980 Mar; 65(3):610-3. PubMed ID: 6444713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective neurotoxicity of clioquinol on the function of the posterior column nuclei.
    Arasaki K; Nakanishi T
    Neurosci Lett; 1989 Dec; 107(1-3):85-8. PubMed ID: 2533335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Founder genetic variants of ABCC4 and ABCC11 in the Japanese population are not associated with the development of subacute myelo-optico-neuropathy (SMON).
    Matsumoto H; Sasai H; Kawamoto N; Katsuyama M; Minamiyama M; Kuru S; Fukao T; Ohnishi H;
    Mol Genet Genomic Med; 2022 Jan; 10(1):e1845. PubMed ID: 34951141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current perception threshold in subacute myelo-optico-neuropathy.
    Suzuki Y; Ogawa K; Shiota H; Kamei S; Oishi M; Mizutani T
    Int J Neurosci; 2010 May; 120(5):368-71. PubMed ID: 20402576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.